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Abstract 
Objective: To investigate factors influencing expenditure levels and the use of potentially detrimental 
coping strategies among tuberculosis (TB) patients. For the purpose of the present study, potentially 
detrimental coping strategies included borrowing money and selling assets. 
Design: Questionnaire survey with an initial and a follow-up interview of each adult new pulmonary 
TB case registered over a period of four months. Conducted in twelve districts with DOTS in 
Tajikistan, one of the poorest countries in the world. 
Results: Patients and their households faced mean expenditures of US$396 related to a TB episode. In 
multivariate mixed-effect regression models, the main determinants of out-of-pocket payments–either 
over the whole course of the disease or after enrolment in DOTS treatment–were ‘complementary 
treatment’ besides the anti-TB drugs, duration of hospitalization and treatment delay. Hereby, 
complementary treatment refers mainly to vitamins and rehydrating infusions. Sex showed no 
association with expenditure. To cope with the costs of illness, two thirds of patients employed a 
potentially detrimental coping strategy. TB patients raised on average US$23 through credits, US$57 
through borrowing money without interest and US$102 through selling assets. 
Conclusion: The catastrophic out-of-pocket payments faced by TB patients are correlated with i) 
receiving complementary treatment, ii) delay to treatment and iii) duration of hospitalisation. The 
widespread use of potentially detrimental coping strategies illustrates that TB constitutes a substantial 
risk of impoverishment. More parsimonious use of complementary treatment and hospitalisation could 
reduce illness-related costs for patients and should be carefully considered. 
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Introduction 
Tuberculosis (TB) patients often encounter high costs during the course of their disease–despite anti-
TB chemotherapy offered for free in most settings (Saunderson 1995, Habib & Baig 2006, 
Kamolratanakul et al. 1999, Wyss et al. 2001, Aspler et al. 2008, Jackson et al. 2006). Anti-TB drugs 
are indeed provided for free in most areas of the Former Soviet Union, but patients have to pay for 
other services including additional medicines, x-rays and laboratory services (Mosneaga et al. 2008). 
In Tajikistan, household costs of an episode of TB amounted to c. US$4900 purchasing power parity 
(PPP), of which US$1840 PPP (38%) were TB-related expenditure (Ayé et al. 2010a). Expenditure 
and loss of income associated with TB may push already poor households deeper into poverty (Russell 
2004) and have been identified as a major barrier to TB services (Wei et al. 2009). Several studies 
observed differing costs depending on socio-economic status and hospitalization (Russell 2004, 
Kamolratanakul et al. 1999, Saunderson 1995); others have shown that the provision of treatment 
observation influences costs to the patients (Saunderson 1995, Floyd et al. 1997). The only study so 
far that statistically tested such observed differences, found clinic-based observation of treatment, 
longer patient-delay and male sex to be the main determinants of higher household costs in urban 
Zambia (Aspler et al. 2008). Overall, the factors associated with high TB-related costs are still poorly 
understood. 
 
Several authors have pointed out that the investigation of household costs of disease is incomplete if 
coping strategies employed by households are ignored (Russell 2004, McIntyre et al. 2006). The most 
immediate response to illness-related costs is to use cash income and savings, but this option is not 
available to all households (McIntyre et al. 2006, Russell 1996). Further common coping strategies are 
borrowing and selling assets. Borrowing can increase the level of debt; sale of assets decreases the 
resilience to future economic shocks (Russell 2004). This is particularly true for the sale of productive 
assets, because this reduces future household income. While there are many more coping strategies 
(cf. Sauerborn et al. 1996, Obrist et al. 2007), available studies emphasize that selling productive 
assets and taking out loans often negatively affect future income and can lead to impoverishment 
(Russell 2004, Leive & Xu 2008, McIntyre et al. 2006, Russell 1996). For the purpose of this article, 
the term “detrimental coping strategies” refers to selling assets and taking out loans. The present study 
aimed at identifying determinants of TB-related out-of-pocket payments and the use of detrimental 
coping strategies in Tajikistan. 
 
Methods 
Study setting and data collection 
WHO (2009) estimated TB incidence in Tajikistan for the year 2007 at 231 cases per 100’000. Roll-
out of the internationally recommended strategy for TB control, DOTS, was ongoing and coverage 
reached 100% by the end of 2007. However, hospitalization rates remain high: 58% in a study in ten 
districts (Thierfelder et al. 2008). This study made use of cost data collected alongside two studies 
investigating i) delay to TB treatment and ii) the timing of costs of illness (Ayé et al. 2010b, Ayé et al. 
2010a). The studies were conducted in twelve districts representing urban, rural, lowland and 
mountainous settings. All adult (≥15 years) new pulmonary TB patients who were registered in the 
twelve districts in the period from 1st December 2006 until 31st March 2007 were eligible. The study 
participants received TB treatment according to the national guidelines of Tajikistan. This involved an 
intensive phase of treatment lasting two months and a continuation phase lasting four months. If 
sputum smear conversion was not achieved after two months, the intensive phase was prolonged by 
one month. 
 
The research team visited patients in hospital or at home during the intensive phase of treatment, 
obtained written informed consent and administered the first questionnaire. Three to four months later, 
a follow-up questionnaire was applied to the same patients. The questionnaires included detailed 
questions about the costs incurred, economic coping strategies and household assets. The first 
questionnaire asked about the period from first symptoms to onset of treatment and the intensive 
phase. The follow-up questionnaire asked about the continuation phase. For analysis, we extrapolated 
costs from the day of the interview until the end of the respective phase. 
 
Statistical analysis 
Three statistical models were built in order to achieve the objectives of the present study and are 
described below. The three outcome variables were: i) total TB-related expenditure, ii) TB-related 
expenditure after onset of treatment and iii) TB-related detrimental coping strategies. 
 
All analyses were conducted in Stata IC/10.1 (Stata Corporation, USA, 1985-2008). We applied 
multiple imputation to our dataset to deal with missing observations as recommended by Manca & 
Palmer (2005) for similar problems and in order to avoid the problems of complete-case analysis 
(Schafer 1997). We built a wealth index based on 18 asset variables (Filmer & Prichett 2001). Details 
on these two steps have been presented elsewhere (Ayé et al. 2010a). 
 
The factors influencing direct costs to households were identified through a mixed-effects linear 
regression. We reduced the number of repeated significance tests by identifying a basic model at the 
outset and by considering only a limited number of predictor variables (Grafen & Hails 2002). We 
built our basic model around five variables. A variable identifying individual DOTS centres had to be 
included in the model based on the design of the survey and was included as a random effect. Three 
variables that had previously been shown to influence household costs were identified from the 
literature, namely sex (Aspler et al. 2008), socio-economic status (Russell 2004, Kamolratanakul et al. 
1999) and hospitalization (Saunderson 1995, Russell 2004). Socio-economic status was included as a 
continuous variable, the wealth index described above. Hospitalization, one of the case management 
factors of main interest, was also included as a continuous variable, namely the log-transformed 
duration of the hospital stay in days. The fifth variable, the second of the main variables of interest 
relating to TB case management, was a binary denoting patients that had received complementary 
treatment, including medication for perceived iatrogenic problems. Two further variables were 
considered in addition to the basic model: the sputum smear result and the total delay from onset of 
symptoms to treatment–both as proxies for the severity of disease and as continuous variables. Both 
the length of hospital stay and the delay until onset of treatment were log-transformed because the 
relationship was expected to have the shape of a saturation curve rather than a linear increase. The full 
model was run, its validity was checked by visually examining the residual errors and then the model 
was simplified by excluding factors with p>0.2. However, the five factors defined from the outset 
were retained even if their p-values were above the threshold (Grafen & Hails 2002). 
 
In order to test more specifically the influence of a case management decision on the costs incurred 
subsequent to this decision, a similar mixed-effects regression model was built, but the outcome 
variable included only those expenditures that were incurred after the onset of anti-TB chemotherapy 
(referred to as “during treatment” below). This model was built in order to test the influence of 
hospitalisation and the use of complementary treatment on TB-related expenditures. The decision, 
whether to hospitalise or whether to use complementary treatment is usually taken at the beginning of 
TB-treatment and cannot have any influence on expenditure made prior to treatment. Also, clinicians 
may want to know, what influence different strategies of case management have on the patient’s 
household economy. Explanatory variables and criteria for model simplification were identical to the 
previous model. 
 
Further, we built a mixed-effects model on the amount of funds mobilized through detrimental coping 
strategies. Taking out loans (with or without interest) and selling assets were considered detrimental 
coping strategies, but not the use of household income, savings and funds received as donations from 
family, friends and other well-doers. For the analysis, we did not differentiate between productive and 
non-productive assets, because the pilot study had shown that by far the largest part of asset sales 
concerned productive assets, most commonly lifestock. The explanatory variables in the model on 
detrimental coping strategies were the same as in the models on expenditure, but an additional variable 
was considered, a binary identifying patients who had worked in Russia until falling ill. This was 
included because it was thought that it could have a major influence on the amount of cash available at 
the household level. 
 
For all three models, we plotted the residuals and checked visually whether they were approximately 
normally distributed. Residuals were close to normally distributed when expenditure data (first two 
models) were log-transformed and when funds mobilized through detrimental coping strategies (third 
model) were root-transformed. 
 
The study has received ethical approval from the Ministry of Health of Tajikistan. 
 
Results 
The study identified 282 eligible patients. Reasons for drop-out and demographic characteristics of the 
204 patients who consented and were interviewed are listed in Tables 1 and 2, respectively. 
 
Expenditure over the whole course of disease 
As reported previously (Ayé et al. 2010a), mean expenditure for an episode of TB amounted to 
US$396 (±standard deviation US$357; median US$282). The full multivariate linear regression model 
for total expenditure was run and simplified as described in the methods section. The factor ‘sputum 
smear result’ was excluded. The final multivariate regression model showed that the delay until onset 
of treatment and complementary treatment were the main determinants of expenditure (Table 3). On 
average, a doubling of the delay led to an increase in total expenditure by 17%. Receiving 
complementary treatment led to an increase in total expenditure by a factor of 2.10. Complementary 
treatment most commonly included Aloe Vera 1% 1ml, glucose 5% infusion, vitamin C 1% 1ml, 
vitamin B1, B6 and B12 (in single and compound formulation), calcium gluconate 10% 10ml, and 
Polyvinylpyrrolidone 6% infusion. There was a statistical tendency for increased costs with longer 
hospital stay (p=0.073). 
 
A slight departure from linearity was observed in the influence of the sputum smear result on total 
expenditure. A sensitivity analysis with sputum smear result as a categorical variable showed fully 
consistent results. 
 
Expenditure during anti-TB therapy 
The regression model on expenditure during treatment could not be simplified. The delay was not 
significantly associated with direct costs during treatment. However, receiving complementary 
treatment and duration of hospital stay were associated with increased expenditure during treatment 
and this was highly significant (Table 4). Receiving complementary treatment led to 2.12 times higher 
expenditure during treatment. Patients hospitalized for one week had 50% higher expenditure 
compared to patients who were not hospitalized. Patients hospitalized for two months had 5.6% higher 
expenditure than patients who were hospitalized for one week only. 
 
There was no statistical relationship between sex and expenditures during treatment. Also the factor 
sputum smear result showed no statistical relationship with expenditure in either of the two models. 
 Coping strategies 
The most common coping strategies were the use of household income, donations received and selling 
assets (Table 5). The highest amounts were raised through household income and selling assets, 
namely on average US$226 (±23.8) and US$102 (±13.3). Two thirds (65.7%) of patients relied on a 
detrimental coping strategy to handle the costs of TB. The mean total amount for all detrimental 
coping strategies was US$182 (±20.8). 
 
The mixed-effects linear regression did not show any statistically significant relationships (Table 6). 
There was a weak statistical tendency (p=0.096) for patients with higher wealth indices to raise less 
money through detrimental coping strategies. Patients who had returned from Russia due to their TB 
showed a statistical tendency (p=0.069) for raising more funds through detrimental coping strategies 
than patients who had not been to Russia. 
 
Discussion 
Limitations 
The present study used an analytic descriptive design and hence it is not possible to definitely 
conclude that a statistical relationship constitutes a causal link. Like other studies investigating 
household costs of illness, we also had to rely on self-reported costs. Consequently, recall and 
reporting bias cannot be excluded (e.g. Saunderson 1995). We limited recall bias by means of 
conducting two interviews, which reduced recall time. Interviewers were trained to recognize 
unusually high costs for specific items and to ask back comparing the reported costs to local prices for 
comparable items. Another limitation is that we have only analyzed two coping strategies, while many 
more exist (Obrist et al. 2007). We have focused on those financial coping strategies that bear risks for 
future impoverishment. 
 
Expenditure 
The main factors leading to higher expenditure related to TB were receiving complementary 
treatment, longer hospital stay and longer treatment delay. The latter two factors were each highly 
significant factors for higher costs in the relevant and appropriate reference period, respectively, but 
only showed a statistical tendency (p<0.1) in the other time period. For hospitalisation, the period 
during treatment is appropriate for analysis, because hospitalisation usually happens during treatment 
and cannot be expected to influence expenditures that had happened previously. The influence of 
hospitalisation was substantial, patients hospitalised for two months having more than 1.5 times as 
high costs as patients who were not hospitalised at all. Longer delay was associated with higher 
expenditure over the whole course of the disease. A similar finding was made in Lusaka, Zambia, 
where longer patient delay led to higher costs (Aspler et al. 2008). Including two proxies for severity 
of disease had very little influence on the estimated coefficients or significance levels of different 
factors–with the exception of the factor hospitalization in the model on costs during the whole 
episode. It seems unlikely that these findings be confounded by severity of disease. The strong 
influence of complementary treatment is most likely related to a tradition among Tajik (and other post-
Soviet–Mosneaga et al. 2008) TB doctors to frequently prescribe additional medication, often several 
types of drugs. An additional reason could be that doctors supplement their meager incomes through 
prescribing and/or selling additional drugs. It has been described for other post-Soviet countries, that 
doctors practice in public premises but for private revenue (Mosneaga et al. 2008). The use of 
additional medication in our study population exceeds international standards by far (WHO 2003) and 
its rationality is doubtful. For the patients, additional medication is associated with the costs of the 
drugs themselves, and with traveling to the health facility for a prescription and to the pharmacy. 
Reducing the use of complementary treatment and of hospitalization could be simple measures to 
decrease the costs to TB patients in Tajikistan. Expenditure was not associated with sex in either of the 
two models. The p-values were high and the two estimated coefficients in the opposite direction. Men 
and women incurred similar expenditure over the course of disease in this study. 
 
Coping strategies 
About two thirds of households employed at least one detrimental coping strategy. The mean amount 
raised was US$182. This high amount suggests that costs associated with an episode of TB push 
affected households deeper into poverty. The proportion of households employing detrimental coping 
strategies is higher than found in 15 African countries, where among hospitalized patients 
(independent of diagnosis), about 50% reported borrowing and/or selling assets (Leive & Xu 2008). 
Most commonly, the assets sold were cattle, sheep or goats. These are productive assets and confirm 
our choice to treat sale of assets as a potentially detrimental coping strategy. 
 
While none of the investigated factors was significantly associated with detrimental coping strategies, 
some aspects are worth discussing. The factor “migration to Russia” showed a tendency towards 
higher use of detrimental coping strategies–rather contrary to expectation. It was assumed that patients 
who recently returned from Russia would on average have more cash available, because wages are 
several times higher in Russia than in Tajikistan. However, the data showed a tendency only and 
should be interpreted with care. The long treatment delays experienced by migrants developing TB in 
Russia could have contributed to higher costs (Ayé et al. 2010b). 
 
In conclusion, patients and their households face major expenditure during an episode of TB and two 
thirds of affected households employ detrimental coping strategies that potentially impair future 
income. Hence household costs of TB are catastrophic. Both sexes experience similar expenditure in 
this setting. The main factors associated with higher expenditure are receiving complementary 
treatment in addition to anti-TB chemotherapy, longer treatment delay and longer stay in hospital. 
Complementary treatment, which is probably questionable on medical grounds in many patients, had 
the strongest effect–more than doubling expenditure. Hospitalisation also had a strong influence, 
mainly on the expenditure during treatment. Reducing additional medication and limiting 
hospitalization are simple interventions at the level of case management that could lead to lower 
expenditure for patients. In view of the high costs, such mitigation strategies are urgently needed. 
Similar health system characteristics and the common use of complementary treatment for TB patients 
suggest that this factor would also play a role for TB patients in other post-Soviet countries (Mosneaga 
et al. 2008). Studies on the impact of these measures on treatment outcomes in the local context would 
be highly informative. 
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Figures & Tables 
Table 1. Reasons for drop-out 
Reason Number of cases (% of drop-
outs) 
Wrong or insufficient address 18   (23) 
Not found at home or in hospital when visited 17   (22) 
Died   5     (6) 
Initial defaulter   3     (4) 
Already in continuation phase when visited 25   (32) 
Did not consent 10   (13) 
Total 78 (100) 
 
Table 2. Characteristics of the 204 study participants 
Age [years] 15 to 24 25 to 34 35 to 44 ≥45   
Women 34 23 15 17   
Men 44 40 15 16   
Total 78 63 30 33   
       
Profession House-
wife 
Migrant 
worker† 
Farmer Petty 
trade 
Un-
employed 
Other 
Women 52   1 11   3   9 14 
Men   0 30 13 19 20 32 
Total 52 31 24 22 29 46 
       
Setting Urban Peri- and semi-
urban 
Rural   
Women 8   3   78   
Men 1   8 106   
Total 9 11 184   
†These patients had returned after labour migration to Russia. 
 
Table 3. Results of the mixed-effects linear regression on total expenditure (in US$, log-
transformed); n=204 
Factor 
 
Coefficient/ 
slope 
S.E.§ 
 
p-value 
 
fmi† 
 
sex    0.147 0.132        0.263 0.160 
wealth index      0.0449   0.0347        0.196 0.130 
days in hospital (log-transformed)      0.0163     0.00910        0.073 0.131 
delay in days (log-transformed)    0.231 0.604 *** <0.0005 0.151 
complementary treatment    0.744 0.280   ** 0.008 0.128 
intercept  3.91 0.392 *** <0.0005 0.139 
DOTS centre (estimate for 
variance-covariance matrix) -1.17 0.420 N/A 0.178 
§S.E.=standard error 
†fmi=fraction of missing information. The fmi is a measure of the information contained in the 
missing data in a multiply imputed dataset (Schafer 1997). 
*denotes significance levels 
 Table 4. Results of the mixed-effects linear regression on expenditure during anti-TB 
chemotherapy (in US$, log-transformed); n=204 
Factor 
 
Coefficient/ 
slope 
S.E.§ 
 
      p-value 
 
fmi† 
 
sex    -0.0586 0.128        0.646 0.141 
wealth index     0.0344   0.0357        0.335 0.204 
sputum smear result     0.0796   0.0613        0.196 0.260 
days in hospital during treatment 
(log-transformed) 
 
    0.0256 
 
    0.00945   ** 0.007 0.192 
delay in days (log-transformed)     0.0994   0.0601        0.099 0.178 
complementary treatment   0.752 0.299     * 0.012 0.261 
intercept 3.98 0.419 *** <0.0005 0.236 
DOTS centre (estimate for 
variance-covariance matrix)  -0.947 0.332 N/A 0.123 
§S.E.=standard error 
†fmi=fraction of missing information. The fmi is a measure of the information contained in the 
missing data in a multiply imputed dataset (Schafer 1997). 
*denotes significance levels 
 
Table 5. Frequency and extent of use of different coping strategies by TB patients; n=204 
 
Proportion of users 
among patients (%) 
Mean 
(in USD) S.E. 
Median among users 
of strategy (in USD) 
Detrimental coping strategies    
Credit   8.41   22.68   7.80 195.28 
Loan 29.97   56.93 15.44   78.57 
Asset sales 49.26 101.93 13.29 190.29 
Total detrimental strategies 65.70 181.54 20.80 207.81 
Non-detrimental coping strategies    
Use of household savings 30.46   63.20 11.08 145.78 
Household income 67.39 226.38 23.78 275.35 
Donations 48.01   38.85   5.53   48.91 
Total non-detrimental strategies 92.28 328.44 24.34 281.80 
Total all strategies 99.10 509.97 31.05 438.33 
 
Table 6. Results of the mixed-effects linear regression on detrimental economic coping strategies 
(in US$, root-transformed); n=204 
Factor 
 
Coefficient/ 
slope 
S.E.§ 
 
p-value 
 
fmi† 
 
sex -4.82 3.09 0.120 0.286 
wealth index -1.22   0.733 0.096 0.200 
sputum smear result 8.19 4.49 0.069 0.365 
days in hospital during treatment 
(log-transformed)   0.269   0.196 0.170 0.273 
complementary treatment 3.31 5.67 0.559 0.135 
intercept 16.5 5.91 0.005 0.143 
DOTS centre (estimate for variance-
covariance matrix) 2.83   0.048 N/A 0.427 
§S.E.=standard error 
†fmi=fraction of missing information. The fmi is a measure of the information contained in the 
missing data in a multiply imputed dataset (Schafer 1997). 
